Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata

PHASE3CompletedINTERVENTIONAL
Enrollment

69,329

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

May 31, 2013

Conditions
DiarrheaCholeraVibrio Infections
Interventions
BIOLOGICAL

bivalent killed whole cell oral cholera vaccine

"Given as 1.5 mL dose, given orally in 2 doses 14 days apart, each dose contains:~V. cholerae O1 Inaba El Tor strain Phil 6973 formalin killed 600 Elisa units (EU) LPS V. cholerae O1 Ogawa classical strain Cairo 50 heat killed 300 EU LPS V. cholerae O1 Ogawa classical strain Cairo 50 formalin killed 300 EU LPS V. cholerae O1 Inaba classical strain Cairo 48 heat killed 300 EU LPS V. cholerae O139 strain 4260B formalin killed 600 EU LPS"

BIOLOGICAL

Placebo

Heat Killed E. coli K12 in an optical turbidity identical to killed oral cholera vaccine, in 1.5 mL oral dose given twice, at least 14 days apart.

Trial Locations (1)

Unknown

National Institute of Cholera and Enteric Diseases, Kolkata

All Listed Sponsors
collaborator

National Institute of Cholera and Enteric Diseases, India

OTHER

collaborator

Shantha Biotechnics Limited

INDUSTRY

lead

International Vaccine Institute

OTHER

NCT00289224 - Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata | Biotech Hunter | Biotech Hunter